Abstract:The fat mass and obesity-associated enzyme (FTO) can catalyze the demethylation of N6-methyladenosine (m6A) residues in mRNA, regulates the cellular level of m6A modification, and plays a critical role in human obesity and cancers. Herein, we develop a single-quantum-dot (QD)-based fluorescence resonance energy transfer (FRET) sensor for the identification of specific FTO demethylase inhibitors. The FTO-mediated demethylation of m6A can induce the cleavage of demethylated DNA to generate the biotinylated DNA fragments, which may function as capture probes to assemble the Cy5-labeled reporter probes onto the QD surface, enabling the occurrence of FRET between the QD and Cy5. The presence of inhibitors can inhibit the FTO demethylation and consequently abolish FRET between the QD and Cy5. The inhibition effect of inhibitors upon FTO demethylation can be simply evaluated by monitoring the decrease of Cy5 counts. We use this nanosensor to screen several small-molecule inhibitors and identify diacerein as a highly selective inhibitor of FTO. Diacerein can inhibit the demethylation activity of endogenous FTO in HeLa cells. Interestingly, diacerein is neither a structural mimic of 2-oxoglutarate (2-OG) nor a chelator of metal ions, and it can selectively inhibit FTO demethylation by competitively binding the m6A-containing substrate.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c02828?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c02828</a>.Sequence of oligonucleotides and the optimization of experimental conditions (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c02828/suppl_file/ac0c02828_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

SFPQ is an FTO-Binding Protein That Facilitates the Demethylation Substrate Preference.

Recruitment of the m6A/m6Am demethylase FTO to target RNAs by the telomeric zinc finger protein ZBTB48

FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis

Recruitment of the m6A/Am demethylase FTO to target RNAs by the telomeric zinc finger protein ZBTB48

Differential M(6)a, M(6)a(m), and M(1)a Demethylation Mediated by FTO in the Cell Nucleus and Cytoplasm

SPI1-induced Downregulation of FTO Promotes GBM Progression by Regulating Pri-Mir-10a Processing in an M6a-Dependent Manner

Differential m6A, m6Am, and m1A Demethylation Mediated by FTO in the Cell Nucleus and Cytoplasm.

Structural insights into FTO’s catalytic mechanism for the demethylation of multiple RNA substrates

Identification of Specific N 6 -Methyladenosine RNA Demethylase FTO Inhibitors by Single-Quantum-Dot-Based FRET Nanosensors

Structural Insights into FTO's Catalytic Mechanism for the Demethylation of Multiple RNA Substrates

N 6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO

FTO regulates adipogenesis by controlling cell cycle progression via mA-YTHDF2 dependent mechanism.

FTO Mediates LINE1 M6a Demethylation and Chromatin Regulation in Mescs and Mouse Development

Demethylase FTO activity analysis based on methyl sensitive enzyme MazF and hybridization chain reaction

Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor.

Crystal Structure of the FTO Protein Reveals Basis for Its Substrate Specificity

Critical roles of FTO-mediated mRNA m6A demethylation in regulating adipogenesis and lipid metabolism: Implications in lipid metabolic disorders

FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms

Sprouts of RNA epigenetics

Studies on the fat mass and obesity-associated (FTO) gene and its impact on obesity-associated diseases

Fat mass and obesity‐associated protein regulates lipogenesis via m 6 A modification in fatty acid synthase mRNA